Use of Pan-vascular Endothelial Growth Factor Receptor (Pan-VEGF) Blockade for the Treatment of Retinopathy of Prematurity (ROP) (Compassionate Use BLOCK-ROP)
Clinical trial NCT00870636 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT00870636
- Sponsor
- Children's Hospital Los Angeles
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.